Biomotum is a startup based in the United States.
Biomotum develops wearable robotic rehabilitation devices (soft exoskeletons) designed for clinical use to improve walking function in individuals with neurologic impairments such as cerebral palsy and stroke. Their SPARK on-demand robotic system is being piloted with clinics and planned for international launch in 2026.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.